FDA Supplement Label Compliance for Gummy Manufacturers: What Your Label Must Get Right

Why Gummy Supplement Labels Attract Extra FDA Scrutiny

Gummy supplements occupy a uniquely complicated regulatory space. They look like candy, they taste like candy, and consumers — including children — often treat them like candy. That reality puts gummy products under a brighter spotlight than capsules or tablets when FDA investigators review labeling. A product that blurs the line between confection and dietary supplement must work harder to establish its identity as a supplement, and the label is the first place FDA looks.

Under 21 CFR Part 101 and the Dietary Supplement Health and Education Act (DSHEA), every dietary supplement sold in the United States must bear specific labeling elements in specific formats. Gummy manufacturers must comply with these same rules, but the format of the product creates additional traps. Net quantity declarations, for example, must reflect the actual serving unit — and when a "serving" is two gummies, the declared net quantity must account for the total count in the package, not just the active ingredient weight. Getting this wrong is a labeling violation even if your formula is perfectly compliant.

FDA enforcement data consistently shows that dietary supplement Warning Letters frequently cite labeling violations: missing or incorrect Supplement Facts panels, unauthorized structure/function claims, and misbranded net quantity statements. For gummy manufacturers specifically, the physical variability introduced by depositing, mogul systems, and gelatin or pectin bloom can create product-to-product weight inconsistencies that compound label accuracy problems. Your label compliance strategy must account for both regulatory text requirements and the manufacturing realities of your specific gummy format.

Mandatory Label Elements Under 21 CFR Part 101

Every dietary supplement label — including gummies — must contain a defined set of information panels and statements. The Principal Display Panel (PDP) is the front face of your package and must include the statement of identity (e.g., "Dietary Supplement" or "Vitamin C Supplement"), the net quantity of contents, and any required warning statements. The Information Panel, which runs to the right of the PDP, carries the Supplement Facts panel, ingredient list, allergen declarations, name and place of business of the manufacturer or distributor, and the directions for use.

For gummy products, the statement of identity deserves particular attention. If your product is a gummy that meets the definition of a dietary supplement under DSHEA, it must be labeled as such. Describing it only as "gummies" or using candy-forward language on the PDP without the supplement identity statement is a misbranding risk. FDA has taken action against products where the labeling created ambiguity about whether the product was a food, a candy, or a supplement.

Key mandatory elements your label must include are:

• Statement of identity — must include the words "dietary supplement" or an equivalent descriptor
• Net quantity of contents — expressed in weight, measure, or numerical count appropriate to the product form
• Supplement Facts panel — formatted per 21 CFR 101.36
• Ingredient list — all inactive and non-dietary-supplement ingredients listed in descending order by weight
• Allergen statement — required under FALCPA for the nine major allergens (note: gelatin derived from certain sources may require disclosure)
• Directions for use — how many gummies constitute a serving, age restrictions if applicable
• Name and address — domestic manufacturer, packer, or distributor
• Lot number and expiration or best-by date — required under 21 CFR Part 111 for traceability

Building a Compliant Supplement Facts Panel for Gummies

The Supplement Facts panel is the most technically demanding element of your label and the area where gummy manufacturers most frequently make errors. 21 CFR 101.36 governs every aspect of this panel: typeface size, column headers, the order in which nutrients are listed, how to express serving size, and when to include percent Daily Value (%DV). The rules are detailed and the FDA takes formatting violations seriously — a panel that lists nutrients in the wrong order or uses a non-compliant typeface can still trigger a Warning Letter even if every ingredient declaration is chemically accurate.

For gummy products, serving size declaration is a recurring problem. Serving size must be expressed in a household measure that makes sense for the product form — for gummies, that is typically "2 gummies" or "1 gummy." It must also be expressed in metric weight in parentheses. The challenge is that gummies produced via depositing lines or mogul systems can have meaningful weight variation between individual pieces, especially when moisture control during cooking and cooling is inconsistent, or when the water activity of the finished product shifts during stability. Your declared serving weight must reflect the actual mean weight of the finished piece, and your manufacturing process must be capable of producing gummies that fall within the label tolerance windows established in 21 CFR 101.9(g).

Nutrient declarations in the Supplement Facts panel must also be accurate within specific tolerances. For vitamins and minerals, the label claim must be met at 100% through the end of shelf life, which means your formulation must account for overages to compensate for degradation during cooking — a particular concern with heat-sensitive vitamins like Vitamin C and certain B vitamins that can lose potency during the gummy cooking and depositing process. Work with your flavor house and contract lab to establish overage percentages based on your specific process parameters: cook temperature, hold time, pH, and water activity all affect vitamin stability in gummy matrices.

Common Supplement Facts panel errors in gummy products include:

• Serving size weight that does not match actual finished gummy weight
• Nutrient declarations that fall below label claim due to cooking losses without adequate overages
• Listing proprietary blends without compliant formatting
• Omitting ingredients used in the gummy matrix (e.g., glucose syrup, citric acid, carnauba wax coating agents) from the ingredient list below the Supplement Facts panel
• Incorrect %DV calculations or using outdated Reference Daily Intake (RDI) values
• Type size below the regulatory minimum for the panel dimensions used

Structure/Function Claims on Gummy Labels: Staying Within Legal Boundaries

Structure/function claims are statements that describe the role of a nutrient or dietary ingredient in supporting normal structure or function in humans — for example, "Vitamin D supports bone health" or "Zinc supports a healthy immune system." These claims are permitted for dietary supplements under DSHEA, but they come with mandatory requirements that many gummy manufacturers either overlook or misapply. Failing to meet these requirements converts a permissible structure/function claim into an illegal disease claim, which can trigger FDA enforcement and, increasingly, retailer delisting.

Any product bearing a structure/function claim must include the disclaimer: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." This disclaimer must appear prominently and conspicuously on the label, in bold type, in a box. It cannot be buried in fine print. Additionally, the manufacturer must notify FDA within 30 days of first marketing a product with a structure/function claim, using the FDA's notification system. Many small gummy manufacturers are unaware of this notification requirement and are technically out of compliance from day one.

The line between a structure/function claim and a disease claim is where enforcement risk concentrates. Claims like "supports heart health" are generally permissible; claims like "reduces the risk of heart disease" are disease claims that require FDA pre-approval as a drug. For gummy products marketed to broad consumer audiences, including children's gummies, the language used in claims warrants careful legal review. FDA has cited gummy supplement companies for disease claims made not just on the label itself, but on Amazon listings, websites, and social media pages associated with the product — all of which FDA considers labeling or advertising subject to enforcement.

Gummy-Specific Labeling Considerations: Net Weight, Coatings, and Allergens

Beyond the standard required elements, gummy manufacturers face labeling considerations that are unique to the product form. Net quantity of contents on the PDP must be declared in terms that are accurate for the product. For gummies, this typically means a count (e.g., "60 Gummies") or a weight declaration, or both. The count declaration must be accurate — a package labeled "60 Gummies" must contain at least 60 gummies. Given the variability that can occur in depositing operations, especially with gelatin-based gummies where bloom strength affects the texture and size of the finished piece, under-count is a real risk that your in-process controls must address.

If your gummies receive a coating — sugar sanding, carnauba wax polishing, or a sugar-free coating system — those coating materials must appear in the ingredient list. Carnauba wax, for example, is a common polishing agent for gummies produced in mogul systems, and it must be declared. Similarly, if your coating system uses any of the nine major allergens — certain wax blends, for example, or equipment shared with allergen-containing products — your allergen statement must reflect that. Gelatin itself, while not one of the nine major allergens, can be a concern for consumers following religious dietary laws or vegan diets, and some retailers now require disclosure. Pectin-based gummies marketed as vegan must ensure that no gelatin is used at any point in the process, including in the coating or dusting stage.

For gummy manufacturers selling through Amazon or major retailers like Walmart or Target, label compliance requirements extend beyond FDA minimums. Amazon's supplement listing policies require that the label match exactly what is displayed in the product listing, and Amazon has removed products for discrepancies between label images and actual label content. NSF International's GMP certification program, which many retailers require or prefer, evaluates label accuracy as part of its audit scope. Treating label compliance as a one-time activity rather than an ongoing quality system element is a mistake — formulation changes, supplier changes, and regulatory updates all require label review.

Building Label Compliance Into Your Quality System

Under 21 CFR Part 111, dietary supplement manufacturers are required to establish and follow written procedures for every step of production, and that includes label control. Your quality system must include a procedure for reviewing and approving labels before production, a process for controlling label versions and preventing use of obsolete labels, and a documented system for reconciling label quantities — how many labels were issued, how many were used, and how many were destroyed. This reconciliation requirement is often cited in FDA 483 observations when it is absent or incomplete.

Label review should be a cross-functional activity. Your QA team reviews the label for regulatory compliance against the current version of 21 CFR Part 101 and Part 111. Your production team reviews it for accuracy against the batch record — does the serving size match actual gummy weight? Does the lot number format match your coding system? Your regulatory affairs team or outside consultant reviews any structure/function claims and the Supplement Facts panel. And ideally, a third-party label review by a GMP consultant with gummy-specific experience catches the errors that internal teams, who are close to the product, tend to overlook.

Finally, build a label change control procedure into your quality system. Any change to your formula — even a seemingly minor excipient substitution, such as switching from one glucose syrup supplier to another — may require a label update if ingredient names, allergen status, or nutrient content changes. Changes to your gummy piece weight, whether driven by a depositing nozzle change or a formula adjustment for texture and water activity, may require an update to the serving size weight declaration. Treating your label as a living document, subject to the same change control rigor as your batch record, is the foundation of sustainable label compliance for gummy supplement manufacturers.